大剂量5-氨基水杨酸灌肠剂治疗溃疡性结肠炎 - Suppr

Suppr

超能文献

Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

作者信息

Campieri M, Lanfranchi G A, Bazzocchi G, Brignola C, Sarti F, Franzin G, Battocchia A, Labo G, Dal Monte P R

出版信息

Lancet. 1981 Aug 8;2(8241):270-1. doi: 10.1016/s0140-6736(81)90523-7.

DOI:10.1016/s0140-6736(81)90523-7

PMID:6114321

Abstract

摘要

相似文献

Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

Lancet. 1981 Aug 8;2(8241):270-1. doi: 10.1016/s0140-6736(81)90523-7.

Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis.

Dig Dis Sci. 1987 Dec;32(12 Suppl):67S-70S. doi: 10.1007/BF01312467.

5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.

Am J Gastroenterol. 1986 Jun;81(6):412-8.

Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study.

Am J Gastroenterol. 1995 May;90(5):736-9.

5-Aminosalicylic acid enemas: effective agent in maintaining remission in left-sided ulcerative colitis.

Gastroenterology. 1988 Apr;94(4):1075-9. doi: 10.1016/0016-5085(88)90569-0.

Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis.

Gut. 1991 Aug;32(8):929-31. doi: 10.1136/gut.32.8.929.

5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada.

Dig Dis Sci. 1987 Dec;32(12 Suppl):64S-66S. doi: 10.1007/BF01312466.

Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas.

Am J Gastroenterol. 1985 Aug;80(8):612-4.

Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial.

Scand J Gastroenterol. 1988 Oct;23(8):1005-8. doi: 10.3109/00365528809090161.

Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial.

Ann Intern Med. 1988 Feb;108(2):195-9. doi: 10.7326/0003-4819-108-2-195.

引用本文的文献

Microenvironmental Factors that Shape Bacterial Metabolites in Inflammatory Bowel Disease.

Front Cell Infect Microbiol. 2022 Jul 15;12:934619. doi: 10.3389/fcimb.2022.934619. eCollection 2022.

Effect of intra-abdominally administered mesalazine (5-aminosalicylic acid) in experimental peritonitis.

North Clin Istanb. 2018 Sep;5(3):171-175. doi: 10.14744/nci.2017.48379.

Efficacy and safety of rectal 5-aminosalicylic acid versus corticosteroids in active distal ulcerative colitis: a systematic review and network meta-analysis.

Sci Rep. 2017 Apr 25;7:46693. doi: 10.1038/srep46693.

GRG Profiles: Lawrence S. Friedman.

Dig Dis Sci. 2015 Apr;60(4):827-31. doi: 10.1007/s10620-015-3599-7.

Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis.

Clin Exp Gastroenterol. 2014 Sep 23;7:369-83. doi: 10.2147/CEG.S35691. eCollection 2014.

"Mucosal healing" in ulcerative colitis: Between clinical evidence and market suggestion.

World J Gastrointest Pathophysiol. 2014 May 15;5(2):54-62. doi: 10.4291/wjgp.v5.i2.54.

Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.

Gut Liver. 2010 Mar;4(1):1-14. doi: 10.5009/gnl.2010.4.1.1. Epub 2010 Mar 25.

Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.

Drugs. 2008;68(8):1089-103. doi: 10.2165/00003495-200868080-00006.

Mechanism of action of 5-arninosalicylic acid.

Mediators Inflamm. 1992;1(3):151-65. doi: 10.1155/S0962935192000243.

How important is onset of action in ulcerative colitis therapy?

Drugs. 2005;65(15):2069-83. doi: 10.2165/00003495-200565150-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验